Related Experiment Video

Updated: Aug 12, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

CNS-aspergillosis: are there new treatment options?

S Schwartz1, E Thiel

  • 1Medizinische Klinik III, Hämatologie, Onkologie und Transfusionsmedizin, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Freie Universität, Hindenburgdamm 30, D-12200 Berlin, Germany. stefan.schwartz@ukbf.fu-berlin.de

Mycoses
|April 2, 2004
PubMed

Insights

Central nervous system (CNS) aspergillosis has a near 100% mortality rate due to poor antifungal drug penetration. Voriconazole shows promise for treating CNS aspergillosis due to its CNS penetration and efficacy.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive aspergillosis significantly impacts immunocompromised patients.
  • Central nervous system (CNS) aspergillosis carries an extremely high mortality rate, approaching 100%.
  • Poor penetration of conventional antifungals (e.g., amphotericin B, itraconazole) into the CNS is a key factor in treatment failure.

Purpose of the Study:

  • To review the pharmacological properties and clinical data of voriconazole for CNS aspergillosis.
  • To evaluate voriconazole's potential to improve outcomes in CNS aspergillosis.
  • To highlight the need for further clinical data on voriconazole's role in CNS aspergillosis.

Main Methods:

  • Compilation of existing pharmacological data on voriconazole.
  • Review of published clinical case studies and series on CNS aspergillosis treated with voriconazole.
  • Analysis of voriconazole's in vitro and in vivo activity against Aspergillus species.

Main Results:

  • Voriconazole exhibits broad-spectrum antifungal activity, including against Aspergillus species.
  • Voriconazole demonstrates superior efficacy in invasive aspergillosis compared to conventional amphotericin B.
  • Voriconazole effectively penetrates the blood-brain barrier, achieving fungicidal concentrations in the CNS.
  • Successful treatment outcomes have been reported in a growing number of CNS aspergillosis patients receiving voriconazole.

Conclusions:

  • Voriconazole's pharmacological profile and demonstrated CNS penetration suggest it may improve outcomes for CNS aspergillosis.
  • Promising clinical data indicate voriconazole as a potential therapeutic option for CNS aspergillosis.
  • Further clinical investigation is required to definitively establish voriconazole's role in managing CNS aspergillosis.

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...